Proliferative diabetic retinopathy (PDR) the sequel of diabetic retinopathy (DR), a frequent
complication of diabetes mellitus (DM), is the leading cause of blindness in the working-age …

Background Diabetic retinopathy (DR) can lead to visual impairment and blindness if not
detected and treated in time. Knowing the barriers/enablers in advance in contrasting …

Background Diabetic retinopathy (DR) has become a leading cause of global blindness as a
microvascular complication of diabetes. Regular screening of diabetic retinopathy is strongly …

Diabetic retinopathy (DR) is the most common cause of blindness in people under the age of
65. Unfortunately, the current screening process for DR restricts the population that can be …

In recent years, the role of artificial intelligence (AI) and deep learning (DL) models is
attracting increasing global interest in the field of ophthalmology. DL models are considered …

Purpose Diabetic retinopathy (DR) is among the leading causes of visual loss in the working‐
age population. It is generally accepted that screening of DR is cost‐effective and can detect …

Diabetic eye disease (DED) is a leading cause of blindness in the world. Annual DED
testing is recommended for adults with diabetes, but adherence to this guideline has …

Importance Diabetic retinopathy is a major complication of diabetes for which regular
screening improves visual health outcomes, yet adherence to screening is suboptimal …

Diabetic retinopathy (DR) is the most common microvascular complication of diabetes that
damages the retina, leading to blindness. People with type 1 diabetes are at greater risk of …

Aims A nationwide diabetic retinopathy (DR) screening program has been established in
Denmark since 2013. We aimed to perform an evaluation of adherence to DR screenings …